Effectiveness and safety of pembrolizumab for the treatment of Japanese patients with microsatellite instability-high tumors excluding colorectal cancer: a post-marketing surveillance.

Jpn J Clin Oncol · 2025 · PMC12319222 · PMID 40382714

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

After starting treatment, the incidence rates (per 100 patient-weeks) of treatment-related AEOSI showed a decreasing trend from 1 to 12 months ( Fig. 4 ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.